Dr Ajani examines the emerging use of immunotherapy in the management of advanced gastric cancer via 2 patient cases.
This activity is intended for oncologists, gastroenterologists, and surgeons.
The goal of this activity is to discuss the latest advances in the use of immunotherapy in patients with advanced gastric cancer.
Approximate Time to Complete: 30 minutes
Credit Available: Dec. 14, 2017 - Dec. 14, 2018
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Have increased knowledge regarding the emerging clinical trial data on the management of gastric cancer
- Have greater competence related to selecting the most appropriate treatment regimen in patients with gastric cancer through the continuum of care
- Have greater competence related to managing treatment-related adverse events in patients with gastric cancer